CRISPR THERAPEUTICS AG Increase (Decrease) in Accounts Receivable
CRISPR THERAPEUTICS AG (CRSP) reported Increase (Decrease) in Accounts Receivable of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-03
- CRISPR THERAPEUTICS AG increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $0.00.
- CRISPR THERAPEUTICS AG increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $0.00.
- CRISPR THERAPEUTICS AG increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- CRISPR THERAPEUTICS AG increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $0.00.
- CRISPR THERAPEUTICS AG increase (decrease) in accounts receivable for fiscal 2025 was -$25.00M.
- CRISPR THERAPEUTICS AG increase (decrease) in accounts receivable for fiscal 2024 was -$175.00M, a 187.50% decline from fiscal 2023.
- CRISPR THERAPEUTICS AG increase (decrease) in accounts receivable for fiscal 2023 was $200.00M.
- CRISPR THERAPEUTICS AG increase (decrease) in accounts receivable for fiscal 2022 was -$305.00K, a 289.44% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $0.00 10-Q · filed 2026-08-03 | $0.00 derived: sum of 3 quarters · filed 2026-08-03 | $0.00 derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-04 | $0.00 derived: sum of 2 quarters · filed 2026-05-04 | $0.00 derived: sum of 3 quarters · filed 2026-05-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-03 | -$25.00M 10-K · filed 2026-02-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-03 | -$25.00M 10-Q · filed 2025-11-10 | $0.00 derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$25.00M 10-Q · filed 2026-08-03 | $0.00 derived: sum of 3 quarters · filed 2026-08-03 | $0.00 derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$25.00M 10-Q · filed 2026-05-04 | $0.00 derived: sum of 2 quarters · filed 2026-05-04 | $0.00 derived: sum of 3 quarters · filed 2026-05-04 | $0.00 derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $25.00M derived: sum of 2 quarters · filed 2026-02-12 | $25.00M derived: sum of 3 quarters · filed 2026-02-12 | -$175.00M 10-K · filed 2026-02-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | -$200.00M 10-Q · filed 2025-11-10 | $0.00 derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$200.00M 10-Q · filed 2025-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-02-12 | -$70.00M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | -$200.00M 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | -$70.00M derived: sum of 3 quarters · filed 2026-02-12 | $0.00 derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $200.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $130.00M derived: sum of 2 quarters · filed 2026-02-12 | $200.00M derived: sum of 3 quarters · filed 2026-02-12 | $200.00M 10-K · filed 2026-02-12 |
| 2023-09-30 | -$70.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $0.00 derived: sum of 2 quarters · filed 2024-11-05 | $0.00 10-Q · filed 2024-11-05 | -$49.00K derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | $70.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $70.00M 10-Q · filed 2024-08-05 | $69.95M derived: sum of 3 quarters · filed 2025-02-11 | $69.93M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | -$49.00K derived: sum of 2 quarters · filed 2025-02-11 | -$66.00K derived: sum of 3 quarters · filed 2025-02-11 | -$143.00K derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | -$66.00K derived: sum of 2 quarters · filed 2025-02-11 | -$143.00K derived: sum of 3 quarters · filed 2025-02-11 | -$305.00K 10-K · filed 2025-02-11 |
| 2022-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$94.00K derived: sum of 2 quarters · filed 2023-11-06 | -$256.00K 10-Q · filed 2023-11-06 | -$103.00K derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | -$77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$239.00K 10-Q · filed 2023-08-07 | -$86.00K derived: sum of 3 quarters · filed 2024-02-21 | -$84.00K derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | -$162.00K 10-Q · filed 2022-05-09 | -$9.00K derived: sum of 2 quarters · filed 2024-02-21 | -$7.00K derived: sum of 3 quarters · filed 2024-02-21 | -$7.00K derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $155.00K derived: sum of 2 quarters · filed 2024-02-21 | $155.00K derived: sum of 3 quarters · filed 2024-02-21 | $161.00K 10-K · filed 2024-02-21 |
| 2021-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $2.00K derived: sum of 2 quarters · filed 2022-11-01 | $8.00K 10-Q · filed 2022-11-01 | $42.00K derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $6.00K 10-Q · filed 2022-08-08 | $40.00K derived: sum of 3 quarters · filed 2023-02-21 | $117.00K derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $6.00K 10-Q · filed 2022-05-09 | $40.00K derived: sum of 2 quarters · filed 2023-02-21 | $117.00K derived: sum of 3 quarters · filed 2023-02-21 | -$24.97M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $111.00K derived: sum of 2 quarters · filed 2023-02-21 | -$24.97M derived: sum of 3 quarters · filed 2023-02-21 | $45.00K 10-K · filed 2023-02-21 |
| 2020-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$25.01M derived: sum of 2 quarters · filed 2021-11-03 | $11.00K 10-Q · filed 2021-11-03 | $71.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | -$25.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$66.00K 10-Q · filed 2021-07-29 | -$6.00K derived: sum of 3 quarters · filed 2022-02-15 | -$288.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $25.02M 10-Q · filed 2021-04-27 | $25.08M derived: sum of 2 quarters · filed 2022-02-15 | $24.80M derived: sum of 3 quarters · filed 2022-02-15 | $24.79M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | -$222.00K derived: sum of 2 quarters · filed 2022-02-15 | -$232.00K derived: sum of 3 quarters · filed 2022-02-15 | $11.00K 10-K · filed 2022-02-15 |
| 2019-09-30 | -$282.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | -$292.00K derived: sum of 2 quarters · filed 2020-10-28 | -$49.00K 10-Q · filed 2020-10-28 | -$513.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | $233.00K 10-Q · filed 2020-07-27 | -$231.00K derived: sum of 3 quarters · filed 2021-02-16 | -$623.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $243.00K 10-Q · filed 2020-04-28 | -$221.00K derived: sum of 2 quarters · filed 2021-02-16 | -$613.00K derived: sum of 3 quarters · filed 2021-02-16 | -$929.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | -$464.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | -$856.00K derived: sum of 2 quarters · filed 2021-02-16 | -$1.17M derived: sum of 3 quarters · filed 2021-02-16 | -$2.54M 10-K · filed 2021-02-16 |
| 2018-09-30 | -$392.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | -$708.00K derived: sum of 2 quarters · filed 2019-10-28 | -$2.07M 10-Q · filed 2019-10-28 | -$2.66M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-06-30 | -$316.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | -$1.68M 10-Q · filed 2019-07-29 | -$2.27M derived: sum of 3 quarters · filed 2020-02-12 | -$5.87M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-03-31 | -$1.37M 10-Q · filed 2019-04-29 | -$1.95M derived: sum of 2 quarters · filed 2020-02-12 | -$5.55M derived: sum of 3 quarters · filed 2020-02-12 | -$4.41M derived: sum of 4 quarters · filed 2020-02-12 |
| 2017-12-31 | -$585.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | -$4.19M derived: sum of 2 quarters · filed 2020-02-12 | -$3.05M derived: sum of 3 quarters · filed 2020-02-12 | -$531.00K 10-K · filed 2020-02-12 |
| 2017-09-30 | -$3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$2.46M derived: sum of 2 quarters · filed 2018-11-07 | $54.00K 10-Q · filed 2018-11-07 | $1.12M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $3.66M 10-Q · filed 2018-08-07 | $4.72M derived: sum of 3 quarters · filed 2019-02-25 | $5.46M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $2.52M 10-Q · filed 2018-05-08 | $3.58M derived: sum of 2 quarters · filed 2019-02-25 | $4.32M derived: sum of 3 quarters · filed 2019-02-25 | $4.71M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $1.80M derived: sum of 2 quarters · filed 2019-02-25 | $2.19M derived: sum of 3 quarters · filed 2019-02-25 | $2.82M 10-K · filed 2019-02-25 |
| 2016-09-30 | $738.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.13M derived: sum of 2 quarters · filed 2017-11-08 | $1.75M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $389.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $1.01M 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | $626.00K 10-Q · filed 2017-05-11 | |||
| 2015-12-31 | $339.00K 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |